Analysis of factors affecting outcome in recipients of bone marrow transplantation for myelodysplasia; a single centre's experience over a nine year period by Stoll, V, Medd, P, Peniket, A, Vyas, P, Littlewood, T, Hatton, C

Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging. by Cahill, T, Chowdhury, O, Myerson, S, Ormerod, O, Herring, N, Grimwade, D, Littlewood, T, Peniket, A

Genes located within the del(9q) commonly deleted region are down-regualted in acute myeloid leukaemia. by Zhao, Z, Daly, S, Yin, J, Sweetser, D, Boultwood, J, Wainscoat, J, Peniket, A

Expression of VEGF, its receptors and hypoxia inducible factors in acute myeloblastic leukaemia by Zhang, Y, Gatter, K, Pezzella, F, Pillai, G, Turley, H, Peniket, A, Zhou, G, Watt, S

Quiz page September 2013: a crystal clear diagnosis. by MacEwen, C, Deshraj, A, Desraj, A, Haynes, R, Roberts, I, Peniket, A, Winearls, C

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. by Campbell, L, Fidler, C, Eagleton, H, Peniket, A, Kusec, R, Gal, S, Littlewood, T, Wainscoat, J, Boultwood, J

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase. by Boultwood, J, Peniket, A, Watkins, F, Shepherd, P, McGale, P, Richards, S, Fidler, C, Littlewood, T, Wainscoat, J

Physical and transcriptional characterization of the commonly deleted region in del(9q) AML. by Daly, S, Wainscoat, J, Side, L, Levy, E, Kusec, R, Kasprzyk, A, Gama, S, Humphray, S, Boultwood, J, Peniket, A

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials. by Peniket, A, Wainscoat, J, Wheatley, K, Side, L, Boultwood, J, Walker, H, Harrison, C, Goldstone, A, Burnett, A

Identification of candidate tumor suppressor genes in the commonly deleted region of del(9q) AML. by Sweetser, D, Daly, S, Haaland-Pullus, C, Side, L, Blomberg, A, Bernstein, I, Wainscoat, J, Boultwood, J, Peniket, A

Telomere length shortening in CML is associated with reduced time to accelerated phase but does not influence overall survival. by Boultwood, J, Watkins, F, Shepherd, P, McGale, P, Richards, S, Fidler, C, Littlewood, T, Peniket, A, Wainscoat, J, Hatton, C

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. by Boultwood, J, Fidler, C, Shepherd, P, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Gaiger, A, Littlewood, T, Peniket, A, Wainscoat, J

10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES by Khan, D, Roy, N, Bari, V, Vallance, G, Dreau, H, Littlewood, T, Peniket, A, Vyas, P, Foroni, L, Schuh, A, Mead, A

Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients by Danby, R, Matin, R, Gibbons, E, Venning, V, Rowly, L, Barton, D, Pawson, R, Littlewood, T, Reed, J, Barton, D, Peniket, A

Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell tran... by Medd, P, Monk, I, Danby, R, Malladi, R, Clifford, R, Ellis, A, Roberts, D, Hatton, C, Vyas, P, Littlewood, T, Peniket, A

Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell tran... by Medd, P, Monk, I, Danby, R, Malladi, R, Clifford, R, Ellis, A, Roberts, D, Hatton, C, Vyas, P, Littlewood, T, Peniket, A

NIH consensus chronic GvHD following T-replete reduced-intensity conditioning sibling allograft usually develops within a year, causes prolonged morbidity but low mortality and is... by Medd, P, Monk, I, Danby, R, Malladi, R, Clifford, R, Ellis, A, Birks, J, Roberts, D, Hatton, C, Vyas, P, Littlewood, T, Peniket, A

Molecular characterization of the chromosome 9q deletion in AML. by Side, L, Peniket, A, Levy, E, Williamson, H, Humphray, S, Langabeer, SE, Walker, H, Goldstone, A, Linch, D, Burnett, A, Boultwood, J, Wainscoat, J

Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia. by Eyre, T, Schwab, C, Kinstrie, R, McGuire, A, Strefford, J, Peniket, A, Mead, A, Littlewood, T, Holyoake, T, Copland, M, Moorman, A, Harrison, C, Vyas, P

Del (9q) AML: clinical and cytological characteristics and prognostic implications. by Peniket, A, Wainscoat, J, Side, L, Daly, S, Kusec, R, Buck, G, Wheatley, K, Walker, H, Chatters, S, Harrison, C, Boultwood, J, Goldstone, A, Burnett, A